Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

BsmI polymorphism in the vitamin D receptor gene is associated with 25-hydroxy vitamin D levels in individuals with cognitive decline.

Oliveira ACR, Magalhães CA, Loures CMG, Fraga VG, Souza LC, Guimarães HC, Cintra MTG, Bicalho MA, Sousa MCR, Silveira JN, Silva IFO, Caramelli P, Carvalho MG, Gomes KB.

Arq Neuropsiquiatr. 2018 Nov;76(11):760-766. doi: 10.1590/0004-282X20180116.

2.

Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer's Disease.

Gagliardi S, Franco V, Sorrentino S, Zucca S, Pandini C, Rota P, Bernuzzi S, Costa A, Sinforiani E, Pansarasa O, Cashman JR, Cereda C.

Front Pharmacol. 2018 Dec 3;9:1404. doi: 10.3389/fphar.2018.01404. eCollection 2018.

3.

Amyloid Beta 1-42 Alters the Expression of miRNAs in Cortical Neurons.

Dursun E, Candaş E, Yılmazer S, Gezen-Ak D.

J Mol Neurosci. 2018 Dec 4. doi: 10.1007/s12031-018-1223-y. [Epub ahead of print]

PMID:
30515701
4.

Molecular basis of vitamin D action in neurodegeneration: the story of a team perspective.

Gezen-Ak D, Dursun E.

Hormones (Athens). 2018 Nov 27. doi: 10.1007/s42000-018-0087-4. [Epub ahead of print] Review.

PMID:
30484097
5.

Is there a role for vitamin D in supporting cognitive function as we age?

Aspell N, Lawlor B, O'Sullivan M.

Proc Nutr Soc. 2018 May;77(2):124-134. doi: 10.1017/S0029665117004153. Epub 2017 Dec 13. Review.

PMID:
29233204
6.

Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases.

Koduah P, Paul F, Dörr JM.

EPMA J. 2017 Nov 15;8(4):313-325. doi: 10.1007/s13167-017-0120-8. eCollection 2017 Dec. Review.

7.

1α,25-Dihydroxyvitamin D3 up-regulates IL-34 expression in SH-SY5Y neural cells.

Zhang D, Li M, Dong Y, Zhang X, Liu X, Chen Z, Zhu Y, Wang H, Liu X, Zhu J, Shen Y, Korner H, Ying S, Fang S, Shen Y.

Innate Immun. 2017 Oct;23(7):584-591. doi: 10.1177/1753425917725391. Epub 2017 Aug 17.

PMID:
28816551
8.

Vitamin D Receptor Regulates Amyloid Beta 1-42 Production with Protein Disulfide Isomerase A3.

Gezen-Ak D, Atasoy IL, Candaş E, Alaylioglu M, Yılmazer S, Dursun E.

ACS Chem Neurosci. 2017 Oct 18;8(10):2335-2346. doi: 10.1021/acschemneuro.7b00245. Epub 2017 Jul 28.

PMID:
28707894
9.

Role of Vitamin D in Amyloid clearance via LRP-1 upregulation in Alzheimer's disease: A potential therapeutic target?

Patel P, Shah J.

J Chem Neuroanat. 2017 Nov;85:36-42. doi: 10.1016/j.jchemneu.2017.06.007. Epub 2017 Jun 30. Review.

PMID:
28669880
10.

Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro.

Dorey E, Bamji-Mirza M, Najem D, Li Y, Liu H, Callaghan D, Walker D, Lue LF, Stanimirovic D, Zhang W.

J Alzheimers Dis. 2017;57(4):1265-1279. doi: 10.3233/JAD-160133.

PMID:
28372324
11.

VITAMIN D IN ALZHEIMER'S DISEASE - PROPHYLAXIS OR THERAPY?.

Gruber-Bzura BM.

Acta Pol Pharm. 2016 Nov;73(6):1427-1431. Review.

PMID:
29634094
12.

Vitamin D receptor gene polymorphisms and cognitive decline in Parkinson's disease.

Gatto NM, Paul KC, Sinsheimer JS, Bronstein JM, Bordelon Y, Rausch R, Ritz B.

J Neurol Sci. 2016 Nov 15;370:100-106. doi: 10.1016/j.jns.2016.09.013. Epub 2016 Sep 11.

13.

Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease.

Landel V, Millet P, Baranger K, Loriod B, Féron F.

Mol Neurodegener. 2016 Mar 1;11:22. doi: 10.1186/s13024-016-0087-2.

14.

1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.

Guo YX, He LY, Zhang M, Wang F, Liu F, Peng WX.

Neuroscience. 2016 May 13;322:28-38. doi: 10.1016/j.neuroscience.2016.01.041. Epub 2016 Jan 25.

PMID:
26820600
15.

Vitamin D and Alzheimer's Disease: Neurocognition to Therapeutics.

Banerjee A, Khemka VK, Ganguly A, Roy D, Ganguly U, Chakrabarti S.

Int J Alzheimers Dis. 2015;2015:192747. doi: 10.1155/2015/192747. Epub 2015 Aug 17. Review.

16.

Vitamin D receptor gene polymorphisms in Alzheimer's disease patients.

Łaczmański Ł, Jakubik M, Bednarek-Tupikowska G, Rymaszewska J, Słoka N, Lwow F.

Exp Gerontol. 2015 Sep;69:142-7. doi: 10.1016/j.exger.2015.06.012. Epub 2015 Jun 18.

PMID:
26093050
17.

Vitamin D receptor polymorphisms and susceptibility to Parkinson's disease and Alzheimer's disease: a meta-analysis.

Lee YH, Kim JH, Song GG.

Neurol Sci. 2014 Dec;35(12):1947-53. doi: 10.1007/s10072-014-1868-4. Epub 2014 Jul 10.

PMID:
25008423
18.

The Effect of Vitamin D Treatment On Nerve Growth Factor (NGF) Release From Hippocampal Neurons.

Gezen-Ak D, Dursun E, Yilmazer S.

Noro Psikiyatr Ars. 2014 Jun;51(2):157-162. doi: 10.4274/npa.y7076. Epub 2014 Jun 1.

19.

1α,25-Dihydroxyvitamin D3 reduces cerebral amyloid-β accumulation and improves cognition in mouse models of Alzheimer's disease.

Durk MR, Han K, Chow EC, Ahrens R, Henderson JT, Fraser PE, Pang KS.

J Neurosci. 2014 May 21;34(21):7091-101. doi: 10.1523/JNEUROSCI.2711-13.2014.

20.

Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Gianforcaro A, Hamadeh MJ.

CNS Neurosci Ther. 2014 Feb;20(2):101-11. doi: 10.1111/cns.12204. Review.

PMID:
24428861

Supplemental Content

Loading ...
Support Center